by Vineti | May 30, 2019
In personalized therapies -- cell therapies, gene therapies, and neoantigen therapies -- a patient is not just the recipient of a drug product. The patient is the product.
by Amy DuRoss | May 22, 2019
One week to go! In the next seven days, those of us working in cell and gene therapy have a great chance to give input that will help our industry grow. See some areas of focus, with screenshots, in this post.
by Marc Puich | May 15, 2019
Standing up the ecosystem your therapy will rely on requires a solid operational plan for how will your therapy move between your key stakeholders.
by Vineti | May 9, 2019
Things move fast in the world of cell and gene therapy. Here are a few of the recent developments we've noted here at Vineti.
by Heidi Hagen | May 2, 2019
When it comes to cell and gene therapy, the four walls of your lab fall away fast.